-Robert Ball Researcher Activity Profile

Research Author Detailed Information 

Robert Ball Publication Rate By Year

Robert Ball has published 9 paper(s) in 2007, 2 paper(s) in 2008, for a total of 11 research publications in total.

Robert R Ball Author Information

LAST NAME: ball

FIRST NAME: Robert

INITIALS: r

AFFILIATION:

Papers

Robert Ball's Publication Record

1. Developmental regression and autism reported to the Vaccine Adverse Event Reporting System. Year Published: 2007
Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA. jane.woo@fda.hhs.gov
2. Chitosan-mediated changes in cell wall composition, morphology and ultrastructure in two wood-inhabiting fungi. Year Published: 2007
Ensis, Wood Processing, Te Papa Tipu Innovation Park, 49 Sala Street, Rotorua, New Zealand.
3. Like father, like son. Year Published: 2007
4. Efficacy of radiofrequency ablation for twin-reversed arterial perfusion sequence. Year Published: 2007
Fetal Treatment Center and the Department of Surgery, University of California, San Francisco, San Francisco, CA 94143-0570, USA. leeh@surgery.ucsf.edu
5. Like father, like son. Year Published: 2007
6. Developmental regression and autism reported to the Vaccine Adverse Event Reporting System. Year Published: 2007
Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852, USA. jane.woo@fda.hhs.gov
7. Effectiveness of influenza vaccination. Year Published: 2007
8. Effectiveness of influenza vaccination. Year Published: 2007
9. Effectiveness of influenza vaccination. Year Published: 2007
10. Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Year Published: 2008
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, USA.
11. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. Year Published: 2008
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, USA. ann.mcmahon@fda.hhs.gov